“We could use that as a tiebreaker” – Yes, but why should we?

By Borgar Jølstad and Erik Gustavsson. Health care priority setting should be based on morally relevant factors such as need, severity, and maximizing health outcomes. But sometimes we must choose between health care allocations where these primary considerations are tied. It is sometimes suggested, and implemented in practice, that in these situations other, perhaps more […]

Read More…

Why we can almost guarantee that genetic enhancement will never be fairly distributed

By Sinead Prince. We’ve been discussing the possibility of genetic enhancement, and the ethics of such technology, for some time now. Many people are quite cautious about the idea of genetically modifying embryos as well as adults, but others have begun waving the green flag rigorously. Genetic enhancement is the modification of genes using technologies […]

Read More…

Patient data for companies: Patient privacy, private profits and the public good

By Adrian Thorogood and Eva Winkler. Our paper tackles a question that policymakers and public healthcare systems are wrestling with around the world: should for-profit companies be given access to medical data derived from patients for research? In public healthcare systems, medical data is generated as part of the routine care of patients, and through […]

Read More…

Does our preoccupation with resilience mean we must tolerate the morally intolerable?

By Rebecca Farrington, Louise Tomkow, Gabrielle Prager, and Kitty Worthing. Healthcare professionals are increasingly expected to be hardy and ‘suck it up’ to survive in complex and demoralising workplaces. As NHS clinicians, we saw staffing shortages and limited resources firsthand during the COVID-19 pandemic. These experiences magnified our scepticism about the onus on us, as […]

Read More…